Evidence that dynorphin plays a major role in mediating progesterone negative feedback on gonadotropin-releasing hormone neurons in sheep.
Endogenous opioid peptides (EOP) mediate progesterone-negative feedback in many species, but the specific EOP systems involved remain unresolved. We first addressed this question in sheep by determining the role of different EOP receptor subtypes in the medial basal hypothalamus (MBH) and preoptic area (POA). Local administration of EOP receptor antagonists to luteal phase ewes indicated that kappa-, but not micro- or delta-, receptors mediate the inhibition of LH secretion in the MBH. In contrast, both kappa- and micro-, but not delta-receptor, antagonists increased LH pulse frequency when placed in the POA. We next examined close appositions between dynorphin (kappa ligand) and beta-endorphin (micro ligand) containing varicosities and GnRH perikarya in luteal phase ewes using dual immunocytochemistry and light microscopy. Approximately 90% of MBH GnRH neurons had close associations by dynorphin-containing varicosities, but only 40-50% of GnRH perikarya elsewhere had such close associations. In contrast, the percentage of beta-endorphinergic varicosities close to GnRH neurons was similar among all regions. Electron microscopic analysis demonstrated both dynorphinergic synapses and beta-endorphinergic synapses onto GnRH perikarya. These and other data lead to the hypothesis that dynorphin neurons play a major role in progesterone-negative feedback in the ewe and that this inhibition may be exerted directly on GnRH perikarya within the MBH, whereas dynorphin and beta-endorphin input to GnRH neurons in the POA provide redundancy to this system or are involved in other actions of progesterone or estradiol in the control of the GnRH surge.
Department of Physiology and Pharmacology, Health Sciences Center North, Medical Center Drive, Morgantown, West Virginia 26506-9229, USA. bgoodman@hsc.wvu.edu
Robert L
RL
Goodman
Lique M
LM
Coolen
Greg M
GM
Anderson
Steven L
SL
Hardy
Miro
M
Valent
John M
JM
Connors
Maureen E
ME
Fitzgerald
Michael N
MN
Lehman
D000818:Animals; D004399:Dynorphins / Q000378:metabolism / Q000502:physiology*; D004723:Endorphins / Q000502:physiology; D025461:Feedback, Physiological; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D007033:Hypothalamus, Middle / Q000166:cytology / Q000502:physiology*; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors; D009474:Neurons / Q000502:physiology*; D011301:Preoptic Area / Q000502:physiology; D011374:Progesterone / Q000502:physiology*; D017473:Receptors, Opioid, kappa / Q000502:physiology; D017450:Receptors, Opioid, mu / Q000502:physiology; D012756:Sheep; D013569:Synapses / Q000502:physiology; D001615:beta-Endorphin / Q000378:metabolism
D004723:Endorphins; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D001615:beta-Endorphin; D004399:Dynorphins; D007986:Luteinizing Hormone